Q. "Antibiotics do not treat viral infections, yet their indiscriminate use has become a major public health concern." Discuss the causes and...

Q. "Antibiotics do not treat viral infections, yet their indiscriminate use has become a major public health concern." Discuss the causes and consequences of antibiotic misuse in India. (10 marks 150 Words)

Question

Q. "Antibiotics do not treat viral infections, yet their indiscriminate use has become a major public health concern." Discuss the causes and consequences of antibiotic misuse in India. (10 marks 150 Words)

Model Answer

Q. "Antibiotics do not treat viral infections, yet their indiscriminate use has become a major public health concern." Discuss the causes and consequences of antibiotic misuse in India. (10 marks 150 Words)

Paper

GS III

Subject

Science & Technology

Syllabus as Per Notification

Science and Technology- Developments and their Applications and Effects in Everyday Life.

Topic

Antibiotics and Misuse

Approach:

Introduction

Introduce by mentioning Antibiotics are effective only against bacterial infections and do not work against viral illnesses such as the common cold or influenza.

Body

Briefly mention the most commonly used Antibiotics in India

Discuss the Causes of Antibiotic Misuse in India

Weak Regulatory Enforcement and Easy Over-the-Counter Access, Over-Reliance on Broad-Spectrum "Watch" Antibiotics, Weak Health-System Capacity, Public Misconceptions and Behavioural Pressures, Antibiotic Misuse in Livestock and Agriculture.

Consequences of Antibiotic Misuse

Emergence of Antimicrobial Resistance (AMR), Reduced Treatment Effectiveness, Increased Healthcare Expenditure and Disease Burden, Environmental Spread of Resistance

Way Forward

Promoting WHO AWaRe-Based Prescribing and Antimicrobial Stewardship, Strengthening Diagnostic Infrastructure, Ensuring Effective Enforcement of Schedule H1, Operationalising the One Health Framework

Conclusion

Conclude by emphasising the need for coordinated strategy can preserve antibiotic effectiveness, contain antimicrobial resistance and strengthen India's health security.

Context

Lancet Public Health highlighted that India uses too many broad-spectrum “watch” antibiotics and too few first-line “access” antibiotics.

Introduction

Antibiotics are effective only against bacterial infections and do not work against viral illnesses such as the common cold or influenza. Yet, their irrational use emerged as a major public health challenge in India. Recent Lancet Public Health (2026) findings show India's growing dependence on broad-spectrum "Watch" antibiotics, while safer "Access" antibiotics remain underutilised, increasing antimicrobial resistance and threatening the sustainability of modern healthcare.

Body

Most commonly used Anti-Biotics in India

Most commonly used antibiotics in India are Amoxicillin-Clavulanate (Augmentin), Azithromycin (Azee/Azithral), and Cefixime (Taxim-O/Monocef).

These are widely prescribed for respiratory tract infections, urinary tract infections and skin infections, but their overuse has contributed significantly to antimicrobial resistance.

Causes of Antibiotic Misuse in India

Weak Regulatory Enforcement and Easy Over-the-Counter Access

Despite antibiotics being regulated under Schedule H1, weak enforcement allows pharmacies to dispense them without valid prescriptions, undermining prescription-only access.

Easy over-the-counter availability encourages self-medication, incomplete treatment courses and indiscriminate antibiotic use, increasing antimicrobial resistance (AMR).

Over-Reliance on Broad-Spectrum "Watch" Antibiotics

Lancet Public Health study estimated India's actual antibiotic consumption at 18.3 Defined Daily Doses (DID) against an optimal 9.9–14.7 DID.

“Watch” antibiotics accounted for 9.3 DID against the recommended 6 DID, while “Access” antibiotics were only 4.5 DID, well below the optimal 7.8 DID.

Weak Health-System Capacity

Limited microbiological laboratories, inadequate rapid diagnostic facilities and weak Antimicrobial Stewardship Programmes (ASPs) encourage empirical prescribing instead of culture-guided therapy.

Public Misconceptions and Behavioural Pressures

Many patients mistakenly believe antibiotics cure fever, cough and common cold, creating pressure on physicians to prescribe them even when infections are viral.

Seasonal influenza outbreaks continue to witness widespread antibiotic consumption despite antibiotics having no effect on viral diseases.

Antibiotic Misuse in Livestock and Agriculture

Antibiotics such as tetracyclines, fluoroquinolone and oxytetracycline are widely used in poultry, dairy and aquaculture for disease prevention and growth promotion, creating selective pressure for resistant bacteria.

Consequences of Antibiotic Misuse

Emergence of Antimicrobial Resistance (AMR)

Repeated and irrational antibiotic exposure enables bacteria to develop resistance, making previously treatable infections increasingly difficult to cure.

Excessive dependence on WHO “Watch” antibiotics increases resistance by exerting greater selective pressure on microbes.

Reduced Treatment Effectiveness

Resistance to Access antibiotics necessitates the use of costlier Reserve antibiotics, narrowing therapeutic options and reducing treatment success.

It also threatens the safety of organ transplantation, chemotherapy, neonatal intensive care and complex surgeries, all of which depend on effective antibiotics.

Increased Healthcare Expenditure and Disease Burden

Drug-resistant infections lead to prolonged hospitalisation, expensive second- and third-line therapies, treatment failures and higher mortality, particularly among newborns, the elderly and immunocompromised individuals.

World Bank estimates that unchecked AMR could significantly reduce global economic output by 2050.

Environmental Spread of Resistance

Hospital effluents, pharmaceutical waste and antibiotic residues contaminate water bodies and soil, creating environmental reservoirs of resistant bacteria and resistance genes.

Way Forward

Promoting WHO AWaRe-Based Prescribing and Antimicrobial Stewardship

National treatment guidelines should prioritise Access antibiotics as first-line therapy while reserving Watch and Reserve antibiotics for clearly defined clinical indications.

Hospitals should institutionalise Antimicrobial Stewardship Programmes (ASPs) as prioritised by National Action Plan on AMR 2.0 (2025–2029)

Strengthening Diagnostic Infrastructure

Strengthening microbiology laboratories and expanding rapid diagnostic and culture facilities under Ayushman Bharat can enable evidence-based prescribing, reducing empirical treatment and ensuring antibiotics are used only when clinically indicated.

Ensuring Effective Enforcement of Schedule H1

Digital prescriptions, barcode-enabled pharmacy monitoring and regular inspections should prevent over-the-counter sale of antibiotics and improve regulatory compliance.

Scaling up the “Red Line Campaign” to promote responsible antibiotic use.

Operationalising the One Health Framework

Integrated surveillance of antimicrobial use and resistance across human health, veterinary medicine, agriculture and the environment should guide evidence-based policy interventions.

The Quadripartite Alliance (WHO–FAO–WOAH–UNEP) identifies One Health as the global framework for tackling AMR.

Conclusion

Antibiotic misuse is not merely a medical issue but a governance, behavioural and One Health challenge. Combating it requires rational prescribing, stronger regulation, robust diagnostics and integrated surveillance across human, animal and environmental sectors. A coordinated strategy can preserve antibiotic effectiveness, contain antimicrobial resistance and strengthen India's health security, advancing the goal of SDG 3 (Good Health and Well-being).

Value Addition:

Three categories of Antibiotics as per WHO

Access: First-choice antibiotics for common infections that have a lower risk of driving resistance.

Watch: Broad-spectrum antibiotics that should be used only for specific infections because they carry a higher risk of promoting antimicrobial resistance.

Reserve: Last-resort antibiotics reserved for treating multidrug-resistant infections.